Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1177
CGON
CG Oncology, Inc. - Common stock
72.21 USD-0.40%+5.49%+20.11%+65.77%6.37 B USD
1324
ORKA
Oruka Therapeutics, Inc. - Common Stock
85.95 USD+1.64%+3.00%+23.26%+168.01%5.18 B USD
1581
OGN
Organon & Co. Common Stock
13.50 USD-0.07%-0.30%+0.45%+85.95%3.55 B USD
1752
MBX
MBX Biosciences, Inc. - Common Stock
55.00 USD-8.39%-4.31%+53.63%+291.18%2.62 B USD

Frequently asked questions about Veradermics, Incorporated Common Stock

What is the Veradermics, Incorporated Common Stock stock price today?

The current price of Veradermics, Incorporated Common Stock (MANE) is 110.44. Over the past 24 hours, the stock has changed by +0.40%. Follow the MANE chart for real-time price dynamics.

What is the stock ticker of Veradermics, Incorporated Common Stock?

Veradermics, Incorporated Common Stock trades under the ticker MANE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Veradermics, Incorporated Common Stock stock going up?

MANE has changed by -8.41% over the last week, +13.95% over the last month, and +234.67% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Veradermics, Incorporated Common Stock have?

As of the latest available data, Veradermics, Incorporated Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Veradermics, Incorporated Common Stock stock?

You can buy Veradermics, Incorporated Common Stock (MANE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Veradermics, Incorporated Common Stock stock?

Investing in Veradermics, Incorporated Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MANE chart and related analysis on metatrader.com as part of your research.